Louisiana State Employees Retirement System’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
AVM
GP
Louisiana State Employees Retirement System's VIR Position: Q2 2026 in Review
Louisiana State Employees Retirement System increased its Vir Biotechnology (VIR) stake by 6.2% in Q2 2026, buying an estimated $29.5K and bringing the position to 53,200 shares worth $542K. The position accounts for 0.01% of the portfolio, ranked #1372.
Louisiana State Employees Retirement System first reported a position in VIR in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.05M in Q2 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.
- Louisiana State Employees Retirement System held 53,200 shares of Vir Biotechnology worth $542K as of Q2 2026.
- Louisiana State Employees Retirement System bought 3,100 Vir Biotechnology shares in Q2 2026, an estimated $29.5K.
- Vir Biotechnology made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1372 holding.
- Louisiana State Employees Retirement System first reported a position in Vir Biotechnology in Q1 2022 and has held it in 18 quarters since.
- Louisiana State Employees Retirement System's Vir Biotechnology position peaked at $1.05M in Q2 2022.
- 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.
Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.